NorthStar Battery

NorthStar Medical Radioisotopes is a commercial-stage radiopharmaceutical company focused on the development, production, and commercialization of diagnostic and therapeutic radioisotopes. The company is the first domestic producer of Molybdenum-99 (Mo-99) in the United States in over 30 years, utilizing an environmentally friendly, non-uranium based production process. Its flagship product, the RadioGenix System, is an innovative automated platform used by radiopharmacies to generate Technetium-99m (Tc-99m) for medical imaging procedures. Beyond diagnostics, NorthStar is expanding its portfolio to include therapeutic isotopes such as Actinium-225 (Ac-225) and Copper-67 (Cu-67) for cancer treatment, and it provides specialized CDMO services for the radiopharmaceutical industry.